Last Updated on July 27, 2024 by The Health Master
Excipient
The Ministry of Health is proposing a major reform to drug labeling in India with respect to excipient details.
This initiative aims to enhance transparency and empower patients with allergies or sensitivities to specific ingredients.
What’s Changing?
The proposed amendment to the Drugs Rules mandates the inclusion of excipient details in the data encoded within QR codes on certain drug labels.
Excipients are inactive ingredients that bind, dilute, or stabilize medications.
Why This Matters
- Informed Decisions: Individuals with allergies to specific excipients, like parabens, can easily identify safe medications using a smartphone QR code scanner.
- Improved Safety: Clearer labeling reduces the risk of allergic reactions caused by undisclosed excipients.
- Enhanced Transparency: Patients gain a more comprehensive understanding of the medication they’re consuming.
Current Scenario and Challenges
Previously, the Ministry considered including excipient names directly on labels.
However, space constraints and practicality concerns led to the exploration of alternative solutions.
The QR Code Solution
The Ministry proposes leveraging QR codes, already mandated on top 300 drug brands, to store excipient information.
This approach offers several benefits:
- Space Efficiency: QR codes can encode significant data without cluttering the label.
- Accessibility: QR codes are easily scannable using free smartphone apps.
- Flexibility: Information can be updated without reprinting labels.
The Road Ahead
The draft amendment is open for public feedback for 30 days.
After considering suggestions, the Ministry will finalize the regulations.
Here’s a Timeline of Key Developments:
- DCC Meeting (September 2023): Highlighted challenges of listing all excipients on labels and recommended QR code or package insert options.
- DTAB Meeting (January 2024): Agreed to capture excipient information in QR codes for top 300 brands initially.
This initiative demonstrates the Ministry’s commitment to patient safety and informed medication use.
Stay tuned for further updates on the implementation of this crucial reform!
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Excipients: Need to enforce stringent Regulatory Standards for quality
DTAB’s Recommendations for Labeling of Excipients
Pharmacy of the World: Addressing Challenges in Excipient Quality
Battle Against Industrial Grade Excipients in Pharma Industry
Excipient Equation: Balancing Safety and Quality in Drug Formulations
USFDA approval granted for the drug for the treatment of Migraine
USFDA grants VAI classification to Cipla at Maharashtra
Stricter Regulations on Schedule G Drug Ads in India
Gist of the draft notification: Compounding of Offences under the Drugs and Cosmetics Act
Govt Considers Price Control on Nutraceuticals in India
Maharashtra FDA conducts raids at three different locations in Vasai
Telangana DCA seizes illegally stocked and overpriced medicines
USFDA approval granted for this chronic heart failure treatment drug
PCI frames new Regulations in accordance with Jan Vishwas Act
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
